SCHEMBL26847383

SCHEMBL26847383

N#Cc1c(SCC2=NC(=O)CN2)[nH]c(=O)c(C#N)c1-c1cccs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 5/20 0.42
▸ MEN1 O00255 5/20 0.42
▸ KMT2A Q03164 5/20 0.42
▸ PRNP P04156 5/20 0.42
▸ RXFP1 Q9HBX9 5/20 0.42
▸ PKM P14618 2/20 0.42
▸ USP2 O75604 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ SAE1 Q9UBE0 1/20 0.42
▸ UBA2 Q9UBT2 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MAPT P10636 4/20 0.41
▸ KDM4E B2RXH2 4/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ HPGD P15428 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAPK10 P53779 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847351 0.84 KDM4E (0.45) NPSR1MEN1KMT2APRNPRXFP1
SCHEMBL24088138 0.81 RXFP1 (0.41) NPSR1MEN1KMT2APRNPRXFP1
SCHEMBL24087933 0.76 NPSR1 (0.44) NPSR1MEN1KMT2APRNPRXFP1
SCHEMBL26847372 0.74 SERPINH1 (0.43) NPSR1MEN1KMT2APRNPRXFP1
SCHEMBL24087883 0.74 MEN1 (0.43) NPSR1MEN1KMT2APRNPRXFP1
SCHEMBL24087884 0.74 ACMSD (0.44) NPSR1MEN1KMT2APRNPRXFP1
SCHEMBL26847375 0.74 KDM4E (0.44) NPSR1MEN1KMT2APRNPRXFP1
SCHEMBL24087888 0.73 RXFP1 (0.50) NPSR1MEN1KMT2APRNPRXFP1
SCHEMBL23850227 0.73 ACMSD (0.68) NPSR1MEN1KMT2APRNPRXFP1
SCHEMBL26847386 0.72 ACMSD (0.46) NPSR1MEN1KMT2APRNPRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 NPSR1 2669/4885MEN1 2572/4885KMT2A 1353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback